Roberts Glore & CO Inc Novartis Ag Transaction History

Roberts Glore & CO Inc

$341 Million
Q3 2024

A detailed history of Roberts Glore & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Roberts Glore & CO Inc holds 14,334 shares of NVS stock, worth $1.48 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

14,334

Previous 14,691 2.43%

Holding current value

$1.48 Million

Previous $1.56 Million 5.37%

% of portfolio

0.48%

Previous 0.48%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $37,888 - $43,157	-357 Reduced 2.43%	14,334 $1.65 Million
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $23,327 - $27,057	-252 Reduced 1.69%	14,691 $1.56 Million
Q1 2024 May 09, 2024	SELL	$95.27 - $108.47 $56,018 - $63,780	-588 Reduced 3.79%	14,943 $1.45 Million
Q4 2023 Feb 12, 2024	SELL	$92.27 - $101.54 $105,649 - $116,263	-1,145 Reduced 6.87%	15,531 $1.57 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $23,682 - $26,282	-250 Reduced 1.48%	16,676 $1.7 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $3,330 - $3,776	-36 Reduced 0.21%	16,926 $1.71 Million
Q1 2023 May 08, 2023	SELL	$80.03 - $92.81 $8,003 - $9,281	-100 Reduced 0.59%	16,962 $1.56 Million
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $28,709 - $35,157	380 Added 2.28%	17,062 $1.55 Million
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $9,018 - $10,500	112 Added 0.68%	16,682 $1.41 Million
Q1 2022 May 02, 2022	BUY	$80.11 - $90.62 $8,011 - $9,062	100 Added 0.61%	16,570 $1.45 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $34,510 - $38,160	-433 Reduced 2.56%	16,470 $1.44 Million
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $4,089 - $4,757	50 Added 0.3%	16,903 $1.38 Million
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $8,524 - $9,415	-100 Reduced 0.59%	16,853 $1.54 Million
Q1 2021 May 06, 2021	SELL	$83.5 - $98.47 $21,877 - $25,799	-262 Reduced 1.52%	16,953 $1.45 Million
Q4 2020 Feb 09, 2021	SELL	$78.07 - $94.43 $1,717 - $2,077	-22 Reduced 0.13%	17,215 $1.63 Million
Q3 2020 Nov 06, 2020	SELL	$82.14 - $91.0 $1,642 - $1,820	-20 Reduced 0.12%	17,237 $1.5 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $40,465 - $45,550	-500 Reduced 2.82%	17,257 $1.51 Million
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $534,863 - $604,741	6,341 Added 55.54%	17,757 $1.68 Million
Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $5,051 - $6,217	-67 Reduced 0.58%	11,416 $1.04 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $33,894 - $38,767	-450 Reduced 3.77%	11,483 $1.1 Million
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $38,966 - $43,388	-529 Reduced 4.24%	11,933 $1.02 Million
Q3 2018 Nov 09, 2018	BUY	$66.94 - $77.43 $12,183 - $14,092	182 Added 1.48%	12,462 $1.07 Million
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $12,982 - $14,672	-200 Reduced 1.6%	12,280 $928,000
Q1 2018 May 08, 2018	SELL	$70.39 - $84.15 $5,279 - $6,311	-75 Reduced 0.6%	12,480 $1.01 Million
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $28,932 - $31,056	-400 Reduced 3.09%	12,555 $1.05 Million
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $18,535 - $19,317	250 Added 1.97%	12,955 $1.11 Million
Q2 2017 Aug 15, 2017	BUY	N/A	12,705	12,705 $1.06 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Account

Roberts Glore & CO Inc Novartis Ag Transaction History